Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis

INTRODUCTION: In evaluating therapies for migraine prevention, emphasis is placed on frequency and less attention is paid to duration or severity. Total pain burden (TPB) combines frequency, duration, and severity of migraine headache, and has the potential to further characterize the benefit of pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailani, Jessica, Andrews, Jeffrey Scott, Tockhorn-Heidenreich, Antje, Wenzel, Richard, Rettiganti, Mallikarjuna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464727/
https://www.ncbi.nlm.nih.gov/pubmed/35930126
http://dx.doi.org/10.1007/s12325-022-02233-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464727/
https://www.ncbi.nlm.nih.gov/pubmed/35930126
http://dx.doi.org/10.1007/s12325-022-02233-y

Ejemplares similares